| ［1］ Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010［J］. CA Cancer J Clin, 2010, 60(5): 277-300.
［2］ Samrao D, Wang D, Ough F, et al. Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy［J］. Transl Oncol, 2012, 5(6): 469-474.
［3］ Costanzo RV, ViláOrtíz GJ, Perandones C, et al. Anp32e/Cpd1 regulates protein phosphatase 2A activity at synapses during synaptogenesis［J］. Eur J Neurosci, 2006, 23(2): 309-324.
［4］ de Bont JM, Kros JM, Passier MM, et al. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis［J］. Neuro Oncol, 2008, 10(5): 648-660.
［5］ Walker BA, Leone PE, Chiecchio L, et al. A compendium of myelomaassociated chromosomal copy number abnormalities and their prognostic value［J］. Blood, 2010, 116(15): e56-65.
［6］ Tsukamoto Y, Uchida T, Karnan S, et al. Genomewide analysis of DNA copy number alterations and gene expression in gastric cancer［J］. J Pathol, 2008, 216(4): 471-482.
［7］ Reilly PT, Afzal S, Wakeham A, et al. Generation and characterization of the Anp32edeficient mouse［J］. PLoS One, 2010, 5(10): e13597.
［8］ Tavazoie SF, Alarcón C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis［J］. Nature, 2008, 451(7175): 147-152.
［9］ Andersen CL, Christensen LL, Thorsen K, et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer［J］. Br J Cancer, 2009, 100(3): 511-523.
［10］ Du Y, Spence SE, Jenkins NA, et al. Cooperating cancergene identification through oncogenicretrovirusinduced insertional mutagenesis［J］. Blood, 2005, 106(7): 2498-2505. |
